sameAs
The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1Dysregulation of D₂-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposureHybrid mouse diversity panel: a panel of inbred mouse strains suitable for analysis of complex genetic traits.A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia.Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning.Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats.Inhibition of stress- or anxiogenic-drug-induced increases in dopamine release in the rat prefrontal cortex by long-term treatment with antidepressant drugs.The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia.Impulsivity in Animal Models for Drug Abuse Disorders.Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli.Sex chromosome complement influences operant responding for a palatable food in mice.Neurofibromin regulates corticostriatal inhibitory networks during working memory performanceRole for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action.Genetic, hormonal, and metabolomic influences on social behavior and sex preference of XXY miceRisk-taking and alcohol use disorders symptomatology in a sample of problem drinkersReduced dysbindin expression mediates N-methyl-D-aspartate receptor hypofunction and impaired working memory performance.In the blink of an eye: relating positive-feedback sensitivity to striatal dopamine D2-like receptors through blink rate.DeltaFosB in the nucleus accumbens regulates food-reinforced instrumental behavior and motivation.Pharmacological enhancement of memory and executive functioning in laboratory animals.Dorsal striatal D2-like receptor availability covaries with sensitivity to positive reinforcement during discrimination learning.Dissecting impulsivity and its relationships to drug addictions.Insight into the relationship between impulsivity and substance abuse from studies using animal modelsA non-human primate system for large-scale genetic studies of complex traits.Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice.Frontal cortical synaptic communication is abnormal in Disc1 genetic mouse models of schizophreniaPrenatal exposure to bisphenol A impacts midbrain dopamine neurons and hippocampal spine synapses in non-human primates.Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administrationIdentifying the molecular basis of inhibitory control deficits in addictions: neuroimaging in non-human primates.Methamphetamine-induced increases in putamen gray matter associate with inhibitory controlCocaine self-administration behavior in inbred mouse lines segregating different capacities for inhibitory control.Poor response inhibition: at the nexus between substance abuse and attention deficit/hyperactivity disorder.Identification of brain transcriptional variation reproduced in peripheral blood: an approach for mapping brain expression traits.Behavioral impairments in rats with chronic epilepsy suggest comorbidity between epilepsy and attention deficit/hyperactivity disorderCognitive deficits in a mouse model of pre-manifest Parkinson's diseaseReversal learning as a measure of impulsive and compulsive behavior in addictions.Cognitive control and the dopamine D₂-like receptor: a dimensional understanding of addiction.Consideration of species differences in developing novel molecules as cognition enhancers.Shaping vulnerability to addiction - the contribution of behavior, neural circuits and molecular mechanisms.Potential molecular mechanisms for decreased synaptic glutamate release in dysbindin-1 mutant miceEffect of acute and repeated treatment with desipramine or methylphenidate on serial reversal learning in rats.
P50
Q28585945-E763C719-67CB-43F1-9E0C-E46E5D27293DQ28729938-A867234C-6298-4AF5-8DDA-A3AA500BF0CDQ30422039-B2413E57-F840-4B88-8039-3B677C98307DQ30465716-EAA7ACE3-B7F6-444E-BBA2-D54AF730B7ADQ30573050-FD97ED21-3573-40FB-9BA4-38F6B53DF271Q31657469-DE8EFA51-6326-426F-B09B-D6C0D590DD37Q31962157-6CCA6C89-B1E6-4461-A2F4-C77BCDAE62F2Q33537860-6D33ADFD-9F4C-4857-8606-444CB207A75DQ33551928-53712F22-75F0-4B94-8302-FE591DC90936Q33767996-BA240E4A-CDA6-401C-8AE8-B54578F7AB2CQ33838542-F9FFE84C-CA72-494C-9567-35CAE565F52AQ34059456-0E0EF9BD-924D-4296-9B33-DB6236D2C10AQ34098188-77BDC22A-325F-4D98-A94E-AD2DCCDE14EFQ34149556-77F7DE80-A7C9-40F9-B4B9-E44AD0EE1C7AQ34199771-9D43A50D-A638-421E-A125-C8BC9771221CQ34379851-F6746A64-0D4D-43AE-A6DE-7586B3B527C8Q34383509-E9D5C1C6-3EB6-4D8A-ACEA-3C4DB8ACF87DQ34564036-4A97711D-20CE-477B-9186-1790DD92413FQ34661221-3A1F3AA2-1D61-4E68-9C3D-95AF080D0A1EQ35044956-261BBA2D-3283-482C-AE59-5746A3E1D1B6Q35180445-5DA6DFD0-13C4-4010-A2FA-0E236D57A99EQ36050384-8E492397-9EDC-4F9A-A315-D53BF5DC853EQ36083103-FAC3A5C3-0E6E-4D25-B691-635E305BEBF9Q36156959-B684C3FF-BF22-4548-A63F-AF4F72D9172BQ36756257-EDBB2A74-61B9-44CC-AD3F-4F3646924216Q36863147-22421176-206F-4A64-B4EE-DEA646293851Q37012177-90B6B3E7-B2BA-434D-9EBE-0025029DB10DQ37064229-BB04DB17-BB3A-48D9-A50A-C424CD111ACAQ37164844-11C658B2-F5FF-4638-A306-F8ACDF7B3F1CQ37164928-1CD8DD35-41FA-465D-AEAB-D8751CABE5ACQ37267702-87DB6931-E22F-4EB7-B314-6F9CC3CC167CQ37397417-5F805A91-E300-4718-BAF1-65FF624511AEQ37624913-9485D913-6BDD-4CA1-B137-1786E6395511Q37669038-8D57EBEC-1388-47B2-BB27-9A1AB543F0FFQ37963739-FA0606E5-D7BB-44BE-9D7E-22BCA9068DC9Q37965451-C01E96DA-7DCC-4E2C-8D72-80E2ECBB4177Q38051975-91693B9D-9F44-4015-BBA7-B8FFF6246CFBQ38676035-BC6728FA-72D0-4B78-BC2C-212E0BD97FB4Q39903496-C974CB0B-D097-43F4-A02F-FBE14BF17F1FQ41877608-DFAEFF32-8A9A-4684-B36C-7DF7EBFB2174
P50
description
American neuroscientist
@en
Amerikaans wetenschapper
@nl
forsker
@nb
name
David Jentsch
@ast
David Jentsch
@es
David Jentsch
@nl
J. David Jentsch
@en
J. David Jentsch
@ga
James Jentsch
@nb
type
label
David Jentsch
@ast
David Jentsch
@es
David Jentsch
@nl
J. David Jentsch
@en
J. David Jentsch
@ga
James Jentsch
@nb
altLabel
David Jentsch
@en
David Jentsch
@es
J. David Jentsch
@es
J. David Jentsch
@nl
James Jentsch
@en
James Jentsch
@es
prefLabel
David Jentsch
@ast
David Jentsch
@es
David Jentsch
@nl
J. David Jentsch
@en
J. David Jentsch
@ga
James Jentsch
@nb
P69
P106
P19
P1960
2MfGnS0AAAAJ
P2002
jdavidjentsch
P21
P31
P496
0000-0002-6483-8844
P569
1972-04-09T00:00:00Z